Medicine and Dentistry
ACE Inhibitor
25%
Angiotensin Receptor Antagonist
25%
Breast Cancer
27%
Cancer
27%
Cancer Associated Fibroblast
25%
Cancer Stem Cell
19%
Case-Control Study
50%
Cell Cycle Progression
25%
Chemoradiotherapy
47%
Colectomy
25%
Colorectal Cancer
100%
Colorectal Carcinoma
25%
Cyclin D1
18%
Cytoreductive Surgery
25%
Diagnostic Marker
25%
Distant Metastasis
34%
Docking (Molecular)
18%
Doxorubicin
25%
Fostamatinib
25%
Hazard Ratio
20%
Hyperthermic Intraperitoneal Chemotherapy
25%
In Silico
35%
Incision
25%
Kaplan Meier Method
22%
Laparoscopic Surgery
25%
Leukocyte Elastase
25%
Liver Metastasis
32%
Lung Adenocarcinoma
25%
Lung Metastasis
32%
Malignant Neoplasm
46%
Metastatic Carcinoma
25%
Neoadjuvant Chemotherapy
25%
Neoplasm
61%
Overall Survival
46%
Pancreas Cancer
25%
Peritoneum Metastasis
25%
Predictive Factor
25%
Prognostic Factor
23%
Proportional Hazards Model
29%
Proto Oncogene
25%
Radiation Therapy
25%
Rectum Cancer
51%
Rectum Carcinoma
75%
Recurrence Risk
20%
Recurrent Disease
19%
Simple Mastectomy
25%
Sphincter
23%
Survival Rate
60%
Total Mesorectal Excision
54%
Triple Negative Breast Cancer
25%
Biochemistry, Genetics and Molecular Biology
Antineoplastic Activity
8%
Binding Affinity
20%
Cancer Cell
19%
Cancer Stem Cell
36%
Catenin
12%
Cell Cycle
16%
Cell Cycle Progression
25%
Cell Invasion
8%
Cell Motility
8%
Cell Oncogene
8%
Cell Proliferation
8%
Cluster of Differentiation
25%
Colon
12%
Computer Model
20%
Cyclin D1
25%
Cytotoxicity
8%
Docking (Molecular)
23%
Doxorubicin
25%
Drug Resistance
13%
Fibroblast
25%
Matrilysin
25%
Molecular Network
5%
Neutrophil Elastase
25%
Neutrophil Granulocyte
5%
Oncogene
8%
Proto Oncogene
25%
Receptor Tyrosine Kinase
8%
Small Molecule
50%
STAT1
25%
Transcription Factors
8%
Tyrosine Kinase
8%
Vascular Endothelial Growth Factor
12%
Vascular Endothelial Growth Factor A
12%
Western Blot
12%
Pharmacology, Toxicology and Pharmaceutical Science
All Cause Mortality
10%
Alternative Complement Pathway C3 C5 Convertase
25%
Angiotensin Receptor Antagonist
25%
Biological Marker
7%
Breast Cancer
25%
Breast Carcinoma
5%
Cancer Staging
10%
Case-Control Study
25%
Chemotherapy
25%
Colon Cancer
28%
Colorectal Cancer
50%
Defined Daily Dose
8%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Disease
5%
Distant Metastasis Free Survival
5%
Epidermal Growth Factor
25%
Fostamatinib
25%
Heme Oxygenase 1
25%
Leukocyte Elastase
25%
Local Recurrence Free Survival
5%
Lung Adenocarcinoma
25%
Lung Cancer
11%
Malignant Neoplasm
38%
Matrilysin
7%
Nuclear Factor
25%
Pancreas Cancer
25%
Reactive Oxygen Metabolite
5%
Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase
25%
Sivelestat
5%
